Boditech Med
Manufacturer and developer of in-vitro diagnostic platforms, reagents, and molecular diagnostics with a focus on point-of-care immunoassays and cartridge-based workflows. The company emphasizes small-sample, rapid assays, automated sample handling and molecular workflows, on-line data connectivity, and global distribution supported by an R&D center and multiple international locations.
Industries
Nr. of Employees
large (251-1000)
Boditech Med
43, Geodudanji 1-gil, Dongnae-myeon, Chuncheon-si, Gangwon-do, Republic of Korea
Patents
Diagnostic cartridge for immunodiagnosis and diagnostic device and system using the same
US-12560602-B2
View DetailsMethod for obtaining lot variation information of a diagnostic cartridge and an in vitro diagnostic device using the same method
US-12547866-B2
View Details
Diagnostic cartridge for immunodiagnosis and diagnostic device and system using the same
US-12560602-B2
View DetailsMethod for obtaining lot variation information of a diagnostic cartridge and an in vitro diagnostic device using the same method
US-12547866-B2
View DetailsProducts
Automated cartridge-based immunoassay analyzers (compact and high-throughput versions)
Automated analyzers that operate with single-use cartridges for immunoassays, available in compact POC and higher-throughput formats and compatible with blood-collection workflows.
Portable fluorescence-based immunoassay analyzers
Compact, portable immunoassay analyzers optimized for point-of-care deployment and small-sample testing.
Automated nucleic acid extraction system
Bench-top automated system for RNA/DNA extraction to prepare samples for downstream PCR-based assays.
Compact real-time PCR instruments with ready-to-use cartridges
Compact PCR instruments designed to run pre-loaded cartridges for rapid qualitative or quantitative detection of pathogens.
Reagent panels for multiple clinical indications
Reagents and test kits covering cardiac, cancer, infectious disease (including tuberculosis and COVID-19), diabetes, fertility/hormone testing, autoimmune, organ function, and therapeutic drug monitoring.
Automated cartridge-based immunoassay analyzers (compact and high-throughput versions)
Automated analyzers that operate with single-use cartridges for immunoassays, available in compact POC and higher-throughput formats and compatible with blood-collection workflows.
Portable fluorescence-based immunoassay analyzers
Compact, portable immunoassay analyzers optimized for point-of-care deployment and small-sample testing.
Automated nucleic acid extraction system
Bench-top automated system for RNA/DNA extraction to prepare samples for downstream PCR-based assays.
Compact real-time PCR instruments with ready-to-use cartridges
Compact PCR instruments designed to run pre-loaded cartridges for rapid qualitative or quantitative detection of pathogens.
Reagent panels for multiple clinical indications
Reagents and test kits covering cardiac, cancer, infectious disease (including tuberculosis and COVID-19), diabetes, fertility/hormone testing, autoimmune, organ function, and therapeutic drug monitoring.
Services
Provision of immunoassay and molecular diagnostic platforms, reagent panels, and customer support for clinical and point-of-care settings.
Provision of immunoassay and molecular diagnostic platforms, reagent panels, and customer support for clinical and point-of-care settings.
Expertise Areas
- Point-of-care diagnostics
- Immunoassay development
- Molecular diagnostics (PCR and nucleic acid extraction)
- Therapeutic drug monitoring
Key Technologies
- Cartridge-based immunoassay systems
- Automated liquid handling
- Whole-blood finger-prick sampling workflows
- Automated nucleic acid extraction
News & Updates
Export permit obtained for a PenKid biomarker assay for rapid acute kidney injury diagnosis.
Agreement to supply key components of cartridges used in chronic disease diagnostics to a partner in China.
Export license obtained for a saliva-based COVID-19 antigen rapid test with short turnaround time.
Quarterly financial update reporting revenue and year-over-year growth.
Company presented automated immunoassay platforms and products at ADLM 2025.
Memorandum of understanding to develop AI-based diagnostics for chronic disease detection and accessibility.
Export permit obtained for a PenKid biomarker assay for rapid acute kidney injury diagnosis.
Agreement to supply key components of cartridges used in chronic disease diagnostics to a partner in China.
Export license obtained for a saliva-based COVID-19 antigen rapid test with short turnaround time.
Quarterly financial update reporting revenue and year-over-year growth.
Company presented automated immunoassay platforms and products at ADLM 2025.
Memorandum of understanding to develop AI-based diagnostics for chronic disease detection and accessibility.